Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Unigene, Shijiazhuang Pharmaceutical Group Co. deal

The companies expanded their Chinese JV by creating the SPG-Unigene Biotechnology Research

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE